RDY $40.45 0.81 (2.0%)
RDY trades on the NYSE.MEMBERSHIP
With headquarters in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, pharmaceutical services and active ingredients, and proprietary products and other, which make up most of the company's revenue at about 80%, 15%, and 3%, respectively. Most of the company's sales are based in the United States.
Q2 Earnings for Apr, May & Jun
Mon, Jul 29, 2019
Since Earnings Report
Q3 Earnings for Jul, Aug & Sep
Fri, Nov 1, 2019Since Earnings Report
Fri, Jul 13, 2018
Dividend Pay Date
Thu, Aug 9, 2018
RDY Industry Competitors
Bausch Health Companies Inc. Common Stock
Elanco Animal Health
Canopy Growth Corporation Common Stock
The Medicines Co
Horizon Pharma PLC
Taro Pharmaceutical Industries Ltd
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.